Valeant Financial Statements
Valeant Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
© 2009 Morningstar, Inc. Financial Data provided by
Valeant Income Statement
| 2008 | 2007 | 2006 | |
|---|---|---|---|
| Revenue ($ mil.) | 657.0 | 872.2 | 907.2 |
| Gross Profit ($ mil.) | 489.1 | 639.1 | 650.3 |
| Operating Income ($ mil.) | (125.9) | 94.2 | 13.9 |
| Total Net Income ($ mil.) | (23.7) | (6.2) | (56.6) |
| Diluted EPS (Net Income) | (0.27) | (0.07) | (0.61) |
Valeant Quarterly Statements
| Quarter Ending Sep 09 | Quarter Ending Jun 09 | Quarter Ending Jun 09 | |
|---|---|---|---|
| Revenue ($ mil.) | 220.3 | 191.7 | 191.7 |
| Gross Profit ($ mil.) | 164.0 | 143.6 | 143.6 |
| Operating Income ($ mil.) | 67.2 | 54.0 | 54.0 |
| Total Net Income ($ mil.) | 37.3 | 32.9 | 32.9 |
| Diluted EPS (Net Income) | 0.44 | 0.39 | 0.39 |
Valeant Stock Quote & Chart
11/09/09 16:02:00 EST •
NYSE •
32.80
•
 +0.3200
•
+0.9852 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Valeant Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 3.52 | 16.45 | 7.01 |
| Price/Earnings Ratio | (84.75) | 384.62 | 25.51 |
| Price/Book Ratio | 7.85 | 3.53 | 6.74 |
| Price/Cash Flow Ratio | 9.73 | 80.00 | 43.48 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Valeant Financial Ratios
Valeant Competitive Intelligence
| Eisai Inc. | Novartis | Roche Holding | |
|---|---|---|---|
| Annual Sales ($ mil.) | 0.0 | 42,584.0 | 45,355.5 |
| Employees | 900 | 96,717 | -- |
| Market Cap ($ mil.) | -- | 119,919.4 | 234,796.4 |
Competitive Landscape
